Clinical Trials Directory

Trials / Completed

CompletedNCT05849441

Mindfulness Program for Adolescents With 22q11DS

Online Mindfulness Intervention for Adolescents With 22q11DS

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Innovation Research & Training · Academic / Other
Sex
All
Age
12 Years – 19 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to evaluate the effectiveness of the Aware Program, an online mindfulness education program, with adolescents with 22q11DS and their parents.

Detailed description

Parent-adolescent pairs (N=60) will be recruited to participate in a randomized controlled trial. Consent, permission, and/or assent will be sought prior to participation in the study. Participant pairs will be randomized into one of two study arms: intervention and wait-list control. All participants will complete a web-based pre-test questionnaire. Adolescents and parents in the intervention group will then receive access to the Aware Program for four weeks. Approximately 4-5 weeks after completing the pre-test questionnaire, all participants will complete a web-based post-test questionnaire (the post-test for the intervention group will include Consumer Satisfaction questions about the program). Adolescents and parents in the wait-list control group will then have the option of reviewing the Aware Program and will receive access for four weeks. After approximately four weeks, they will have the opportunity to complete the Consumer Satisfaction Questionnaire about the program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAware ProgramThe program includes interactive, multimedia lessons for adolescent participants to learn, practice, and apply different mindfulness skills. Parent-adolescent pairs will have the option to subscribe to a mobile messaging service that includes progress reminders, encouragement, and practice content. Parent participants also have access to online resources to support and monitor their teen's use of the program.

Timeline

Start date
2023-12-18
Primary completion
2024-08-17
Completion
2024-08-17
First posted
2023-05-08
Last updated
2025-04-29
Results posted
2025-04-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05849441. Inclusion in this directory is not an endorsement.